This inventor holds 2 USPTO granted patents. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1997
Title: Willi Bielenberg: Innovator in Pharmaceutical Compounds
Introduction
Willi Bielenberg is a notable inventor based in Alfeld/Leine, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have heart rate lowering and anti-ischemic effects. With a total of two patents to his name, Bielenberg's work is recognized for its potential impact on medical treatments.
Latest Patents
Bielenberg's latest patents include innovative compounds described as (Phenylalkylaminoalkyloxy)-heteroaryl compounds. These compounds are characterized by their heart rate lowering and anti-ischemic effects. The patents detail methods for their preparation and pharmaceutical compositions containing these compounds. The compounds correspond to specific general formulas, which are outlined in the patent specifications.
Career Highlights
Willi Bielenberg is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in advancing pharmaceutical research. His expertise in the synthesis of complex compounds has contributed to the company's reputation in the industry. Bielenberg's work exemplifies the intersection of chemistry and medicine, showcasing the importance of innovation in healthcare.
Collaborations
Throughout his career, Bielenberg has collaborated with notable colleagues, including Wolfgang Kehrbach and Michael Mlinaric. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile